OTHER NEWS - Oct. 8, 1991
- Share via
From Times Staff and Wire Reports
Upjohn Says Stock Report Was Phony: Upjohn Co. officials asked the SEC to investigate what it said was a phony report of an offer to buy 50 million shares of the drug company’s stock. The report, sent by facsimile to brokerages, said a cash offer of $69.50 a share would begin Wednesday. The company’s stock fell 25 cents a share Monday to $43.25 on the New York Stock Exchange.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
